Many factors are involved in transforming pancreatic cancer into a highly aggressive and metastatic disease, such as alterations in cell-cell interaction [11], deregulated expression of extracellular proteases [12], and metastasis-associated genes such as KAI-1, heparanase [13,14] and a number of other molecules. The gene discussed is CD82; the disease is pancreatic neoplasm.